Weight loss plateau or reversal
It is likely that insurers, and Medicare, will revise their coverage on the basis of the trial to cover the drug for high-risk patients that fit the entry criteria of the trial, but that will represent a very large economic burden to cover the drug cost
Cardiovascular result studies indicate diminished hospitalization expenses, while prolonged weight reduction advantages may lower obesity-related healthcare use, encompassing joint replacement procedures, sleep apnea interventions, and cancer screening expenditures
JACC Heart failure (2023) 11(8 Pt 1):100010
I mean, there's just so much we can learn here from the proteomics
Utilizing the concept of elevating GLP-1 concentrations, DPP-4 inhibitors as oral agents and synthetic injectable, DPP-4 resistant GLP-1 receptor agonists (GLP-1RA) were introduced as treatment options for T2D therapy (36)